These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12932646)

  • 1. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer.
    Almond BA; Hadba AR; Freeman ST; Cuevas BJ; York AM; Detrisac CJ; Goldberg EP
    J Control Release; 2003 Aug; 91(1-2):147-55. PubMed ID: 12932646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of a particulate formulation for the intraperitoneal application of mitoxantrone.
    Luftensteiner CP; Schwendenwein I; Eichler HG; Paul B; Wölfl G; Viernstein H
    Int J Pharm; 1999 Apr; 180(2):251-60. PubMed ID: 10370195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats.
    Luftensteiner CP; Schwendenwein I; Paul B; Eichler HG; Viernstein H
    J Control Release; 1999 Jan; 57(1):35-44. PubMed ID: 9863037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma.
    Jameela SR; Latha PG; Subramoniam A; Jayakrishnan A
    J Pharm Pharmacol; 1996 Jul; 48(7):685-8. PubMed ID: 8866329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, properties, and intratumoral evaluation of mitoxantrone-loaded casein microspheres in Lewis lung carcinoma.
    Knepp WA; Jayakrishnan A; Quigg JM; Sitren HS; Bagnall JJ; Goldberg EP
    J Pharm Pharmacol; 1993 Oct; 45(10):887-91. PubMed ID: 7904628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on mitoxantrone albumin microspheres for liver targeting].
    Zhang ZR; Qian WJ
    Yao Xue Xue Bao; 1997; 32(1):72-8. PubMed ID: 11243225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
    Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
    Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations.
    Cheung RY; Rauth AM; Yu Wu X
    Anticancer Drugs; 2005 Apr; 16(4):423-33. PubMed ID: 15746579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells.
    Bozdağ S; Capan Y; Vural I; Dalkara T; Dogan AL; Guc D; Hincal AA; Deluca PP
    J Microencapsul; 2004 Nov; 21(7):751-60. PubMed ID: 15799225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
    DiMeco F; Li KW; Tyler BM; Wolf AS; Brem H; Olivi A
    J Neurosurg; 2002 Nov; 97(5):1173-8. PubMed ID: 12450040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumors.
    Saini M; Roser F; Hussein S; Samii M; Bellinzona M
    J Neurooncol; 2004 Jul; 68(3):225-32. PubMed ID: 15332325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits.
    Ramirez LH; Zhao Z; Rougier P; Bognel C; Dzodic R; Vassal G; Ardouin P; Gouyette A; Munck JN
    Cancer Chemother Pharmacol; 1996; 37(4):371-6. PubMed ID: 8548884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone.
    Raghunand N; Mahoney B; van Sluis R; Baggett B; Gillies RJ
    Neoplasia; 2001; 3(3):227-35. PubMed ID: 11494116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
    Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
    J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.